...
首页> 外文期刊>The journal of headache and pain >EHMTI-0384. A double blind randomized placebo controlled trial for non-invasive dynamic trans-cutaneous electrical nerves stimulation in management of tension type headaches
【24h】

EHMTI-0384. A double blind randomized placebo controlled trial for non-invasive dynamic trans-cutaneous electrical nerves stimulation in management of tension type headaches

机译:EHMTI-0384。双张力随机安慰剂对照试验,用于无创动态经皮电神经刺激治疗紧张型头痛

获取原文
           

摘要

Tension-type headaches (TTH) are the most common type of headaches, and new non-invasive modalities might improve their better management. Dynamic transcutaneous electrical nerves stimulation (dTENS) is one of them. We designed a protocol for a randomized double blind placebo controlled clinical trial to assess the effects of dTENS for patients with chronic TTH. dTENS is added to the standard management with no changes in routine practice. We invite for this study adolescents, adults and elderly patients who consented to participate. Specially designed headache diaries, HALT, HART indices and clinical interview are included as the major outcomes measures. The zones, intensity and duration for dTENS application were recommended and modified by physical therapist (L.G.) and acupuncture specialist (M.N.). They included the zones (on the head and neck) and dosage recommended by the manufacturer. The course of dTENS study consists of 10 procedures performed by clinicians (D.V. and G.R.) who were trained for this. All participants of the study are randomized into two groups using a computer-based software. Placebo-devices were made for this trial by the manufacturer (DENAS Corporation, Ekaterinburg, Russia). The sham-devices look and sound exactly as the active ones, but electrodes are not connected to the electrical stimulator. These compact devices for dTENS are approved for using in medical settings and at home, and this trial might add evidence for physicians when prescribing them to patients.
机译:紧张型头痛(TTH)是最常见的头痛类型,新的非侵入性治疗方法可能会改善其更好的治疗效果。动态经皮电神经刺激(dTENS)就是其中之一。我们设计了一项随机双盲安慰剂对照临床试验的方案,以评估dTENS对慢性TTH患者的影响。 dTENS被添加到标准管理中,而常规操作没有任何变化。我们邀请参与的青少年,成人和老年患者参加本研究。特别设计的头痛日记,HALT,HART指数和临床访谈均作为主要结局指标。物理治疗师(L.G.)和针灸专家(M.N.)推荐并修改了dTENS应用的区域,强度和持续时间。它们包括制造商建议的区域(在头部和颈部)和剂量。 dTENS研究课程包括由受过此培训的临床医生(D.V.和G.R.)执行的10个程序。使用基于计算机的软件,将研究的所有参与者随机分为两组。安慰剂设备是由制造商(DENAS Corporation,俄罗斯叶卡捷琳堡,俄罗斯)制造的。假设备的外观和声音与活动设备完全相同,但电极未连接到电刺激器。这些用于dTENS的紧凑型设备已获批准在医疗环境和家庭中使用,该试验可能为医师开具处方给患者提供证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号